Anxiety and depressive disorders have increased by 25 percent just in the first year of the COVID-19 pandemic and there is a strong need to address the growing treatment gap.
Drug therapies using psychedelic drugs, once considered taboo, are slowly making their way to the mainstream.
Influenced by softening laws on personal consumption and the medical acceptance of cannabis, it's likely we'll see more widespread research into their use in treating debilitating mental health and addiction disorders.
